(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -38.72%822.97K | -49.38%909.03K | -49.38%909.03K | -49.76%1.06M | -47.38%1.23M | -48.47%1.34M | -49.81%1.8M | -49.81%1.8M | -43.80%2.11M | -53.50%2.34M |
-Cash and cash equivalents | -38.72%822.97K | -49.38%909.03K | -49.38%909.03K | -49.76%1.06M | -47.38%1.23M | -48.47%1.34M | -49.81%1.8M | -49.81%1.8M | -43.80%2.11M | -53.50%2.34M |
Total current assets | -39.65%869.55K | -49.28%987.62K | -49.28%987.62K | -49.33%1.14M | -47.43%1.29M | -50.12%1.44M | -48.65%1.95M | -48.65%1.95M | -44.17%2.25M | -52.96%2.45M |
Non current assets | ||||||||||
-Accumulated depreciation | ---- | --0 | --0 | -38.46%-164.36K | -52.17%-159.79K | -60.00%-146.09K | -70.59%-132.4K | -70.59%-132.4K | -85.71%-118.7K | -109.09%-105.01K |
-Long term equity investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -91.38%5.44K |
-Other intangible assets | -7.49%1.42M | -22.63%1.42M | -22.63%1.42M | -22.47%1.42M | --1.54M | --1.54M | -65.25%1.84M | -65.25%1.84M | --1.84M | ---- |
Regulatory assets | -75.00%17.67K | -67.34%36.72K | -67.34%36.72K | -34.99%65.47K | -55.07%41.44K | -72.25%70.7K | -36.43%112.41K | -36.43%112.41K | -56.35%100.7K | -44.27%92.23K |
Total assets | -75.00%17.67K | -67.34%36.72K | -67.34%36.72K | -34.99%65.47K | -55.07%41.44K | -72.25%70.7K | -36.43%112.41K | -36.43%112.41K | -56.35%100.7K | -44.27%92.23K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current debt and capital lease obligation | ---- | ---- | ---- | ---- | -90.57%5.44K | -64.44%20.21K | -37.92%34.75K | -37.92%34.75K | -10.65%49.06K | 6.35%57.71K |
-Current capital lease obligation | ---- | --0 | --0 | --0 | -90.57%5.44K | -64.44%20.21K | -37.92%34.75K | -37.92%34.75K | -10.65%49.06K | 6.35%57.71K |
-accounts payable | 1,120.16%40.19K | 302.17%13.73K | 302.17%13.73K | -64.20%17.95K | 266.95%20.19K | -98.26%3.29K | -98.47%3.41K | -98.47%3.41K | -70.83%50.16K | -99.02%5.5K |
-Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -91.38%5.44K |
Current accrued expenses | -0.66%208.13K | -1.22%202.5K | -1.22%202.5K | -2.24%196K | -2.42%191.5K | -6.79%209.5K | 0.00%205K | 0.00%205K | 0.25%200.5K | -10.59%196.25K |
Current liabilities | 6.57%248.32K | -11.08%216.23K | -11.08%216.23K | -28.61%213.95K | -16.32%217.13K | -50.57%233K | -49.83%243.17K | -49.83%243.17K | -29.78%299.72K | -75.50%259.46K |
Non current liabilities | ||||||||||
-Long term debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | -91.38%5.44K |
Non current accrued expenses | ---- | --0 | --0 | --0 | -92.31%4.57K | -75.00%18.26K | -63.16%31.96K | -63.16%31.96K | -54.55%45.65K | -48.00%59.35K |
Total non current liabilities | 6.57%248.32K | -11.08%216.23K | -11.08%216.23K | -28.61%213.95K | -18.03%217.13K | -52.60%233K | -53.18%243.17K | -53.18%243.17K | -37.05%299.72K | -76.39%264.9K |
Shareholders'equity | ||||||||||
Share capital | 0.00%13.88M | 0.00%13.88M | 0.00%13.88M | 0.00%13.88M | 0.00%13.88M | 0.00%13.88M | 0.00%13.88M | 0.00%13.88M | 0.52%13.88M | 0.57%13.88M |
-common stock | 0.00%13.88M | 0.00%13.88M | 0.00%13.88M | 0.00%13.88M | 0.00%13.88M | 0.00%13.88M | 0.00%13.88M | 0.00%13.88M | 0.52%13.88M | 0.57%13.88M |
Gains losses not affecting retained earnings | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.49%5.28M |
Total equity | -40.40%869.55K | -50.10%987.62K | -50.10%987.62K | -50.34%1.14M | -48.49%1.29M | -50.73%1.46M | -48.97%1.98M | -48.97%1.98M | -44.42%2.29M | -52.86%2.51M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.